Rebalix
Logo iSharesiShares · sheet of 20 October 2026
ETF sheet · official issuer and register data

iShares U.S. Equity High Income Active UCITS ETF

INCI · IE0007FM00T9 · USD · domicile Ireland
Equity · United States · Large & mid cap · DividendactiveSFDR art. 8
Comparison benchmark: S&P 500 Index
TER
0.35%+ trans. 0.25%
Fund size
4 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
25.72%white list 2.05%
Replication
Gestione attiva (dal KID)active management
Income
Accumulating
Launch 22 Mar 2024 · costs from the KID as of 2 Oct 2026 · 338 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is actively managed and aims to generate income and capital growth with lower volatility than the broader US equity market. In normal market conditions, the Fund will invest at least 80% of its total assets in the equity and equity-related instruments (namely, call options, futures and swaps) of large capitalisation companies domiciled in, listed in, or the main business of which is in, the United States of America. The Fund will also invest in accordance with its ESG Policy as outlined in the Fund’s prospectus. In order to achieve its…

Performance since series start (in euro) — base 100

22 Mar 2024 → 16 Oct 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2025202614295139
High 142 (12 Oct 2026) · low 95 (8 Apr 2025) · last 139. Past performance is not indicative of future results.

Returns in euro

1 year+21.7%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+39.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)10.52%10.52%—
Max drawdown−7.22%−7.22%—
Sharpe1.451.45—
Sortino2.152.15—
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · INCI · IE0007FM00T91
RebalixINCI · IE0007FM00T9 · sheet of 20 October 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+13.89%+17.43%−3.54%

Holdings

Portfolio as declared by the issuer · 30 Sept 2026 · 338 securities · top-10 weight = 32.7%
Top holdingsWeight
NVIDIA7.6%
APPLE6.2%
MICROSOFT5.0%
AMAZON.COM INC3.1%
ALPHABET CLASS C2.4%
BROADCOM INC2.1%
BERKSHIRE HATHAWAY INC CLASS B1.7%
ALPHABET CLASS A1.7%
MICRON TECHNOLOGY1.5%
COSTCO WHOLESALE CORP1.4%
Countries (% of fund)
United States96.9%Ireland3.5%Sweden0.1%
Sectors (% of fund)
Information Technology37.2%Financials10.8%Health Care10.1%Communication9.7%Consumer Discretionary7.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
INCI · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Hamburg, Börse Hannover, Euronext Amsterdam, SIX Swiss Exchange, Tradegate Exchange, Xetra (Deutsche Börse)
+ 5 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish…
Factsheet · www.blackrock.com/uk/literature/fact-sheet/inci-ishares-u-s-equity-hig…
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares…
The live sheet, always up to date
rebalix.com/en/etf/IE0007FM00T9
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · INCI · IE0007FM00T92